BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06350097-completion@plaintrial.com
DTSTAMP:20261027T031804Z
DTSTART;VALUE=DATE:20320525
SUMMARY:Phase III\, Open-label Study of First-line Osimertinib With or With
 out Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-sm
 all Cell Lung Cancer — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06350097
URL:https://plaintrial.com/trial/NCT06350097
END:VEVENT
END:VCALENDAR